scholarly article | Q13442814 |
P2093 | author name string | Xue Zhang | |
Xiaodong Ma | |||
Yuanshen Huang | |||
Yabin Cheng | |||
Liren Tang | |||
Joshua Jiawei Zhou | |||
P2860 | cites work | Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions | Q24313501 |
The EYA tyrosine phosphatase activity is pro-angiogenic and is inhibited by benzbromarone | Q28482486 | ||
Eyes absent represents a class of protein tyrosine phosphatases | Q28593158 | ||
The current status of S-100B as a biomarker in melanoma | Q34246618 | ||
Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers | Q34538752 | ||
Current concepts of metastasis in melanoma. | Q34610427 | ||
Decreased expression of nuclear p300 is associated with disease progression and worse prognosis of melanoma patients | Q35010007 | ||
Cooperative effects of INK4a and ras in melanoma susceptibility in vivo | Q35195311 | ||
Chromatin structure following UV-induced DNA damage-repair or death? | Q35600207 | ||
Increased expression of neuropilin 1 in melanoma progression and its prognostic significance in patients with melanoma. | Q35728896 | ||
Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis. | Q36356155 | ||
The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis | Q36691376 | ||
EYA1 phosphatase function is essential to drive breast cancer cell proliferation through cyclin D1. | Q37128230 | ||
ING4 regulates JWA in angiogenesis and their prognostic value in melanoma patients | Q37352611 | ||
Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities. | Q37737945 | ||
Up-regulation of SERPINA3 correlates with high mortality of melanoma patients and increased migration and invasion of cancer cells | Q37745812 | ||
Proteases in cutaneous malignant melanoma: relevance as biomarker and therapeutic target. | Q37777976 | ||
The immune system--a hidden treasure for biomarker discovery in cutaneous melanoma | Q38040807 | ||
Tumor profiling using protein biomarker panels in malignant melanoma: application of tissue microarrays and beyond. | Q38042458 | ||
Biomarker use is associated with reduced clinical trial failure risk in metastatic melanoma | Q38326094 | ||
Targeted agents and immunotherapies: optimizing outcomes in melanoma | Q38856722 | ||
Key regulators of apoptosis execution as biomarker candidates in melanoma | Q38866722 | ||
JWA inhibits melanoma angiogenesis by suppressing ILK signaling and is an independent prognostic biomarker for melanoma | Q39092319 | ||
Prognostic significance of Fbw7 in human melanoma and its role in cell migration | Q39199650 | ||
Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis | Q39721556 | ||
Osteopontin expression correlates with melanoma invasion. | Q40430550 | ||
Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma | Q48240295 | ||
The Drosophila eyes absent gene directs ectopic eye formation in a pathway conserved between flies and vertebrates. | Q52191447 | ||
Analysis of Trends in US Melanoma Incidence and Mortality. | Q53618642 | ||
Reduced expression of SRY-box containing gene 17 correlates with an unfavorable melanoma patient survival. | Q55070683 | ||
Expression of apoptosis regulators in cutaneous malignant melanoma | Q77151107 | ||
Endothelin-3 is produced by metastatic melanoma cells and promotes melanoma cell survival | Q80886786 | ||
Collagen triple helix repeat containing 1 promotes melanoma cell adhesion and survival | Q83815491 | ||
Alpha 1 antichymotrypsin is aberrantly expressed during melanoma progression and predicts poor survival for patients with metastatic melanoma | Q84159977 | ||
EYA1 expression in gastric carcinoma and its association with clinicopathological characteristics: a pilot study | Q87675280 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 62 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 105081-105092 | |
P577 | publication date | 2017-09-27 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | Eyes absent gene (EYA1) is a pathogenic driver and a therapeutic target for melanoma | |
P478 | volume | 8 |
Search more.